Showing 301-310 of 353 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Type 1 Diabetes Consortium – New Onset Workstream | Critical Path Institute (C-Path) | Joseph Hedrick | Cures | 28-October-2022 to 31-December-2026 | $1,560,723.00 |
| Clinical Translation of NICHE for pancreatic islet transplantation for T1D | Continuity Biosciences | Alessandro Grattoni | Cures | 01-March-2026 to 28-February-2030 | $2,675,316.00 |
| Engineered Nanocapsules for Targeted Drug Delivery to the β-Cell | Colorado School of Mines | Nikki Farnsworth | Cures | 01-April-2023 to 31-December-2026 | $900,000.00 |
| ALIGN-T1D Start-Up Secretariat | Clinton Health Access Initiative (CHAI) | Colin Brown | Mission | 01-October-2025 to 31-March-2027 | $822,000.00 |
| Closing the T1D diagnosis gap in Ethiopia, Ghana and Nigeria | Clinton Health Access Initiative (CHAI) | Margaret Prust | Mission | 01-September-2023 to 31-August-2026 | $1,702,076.57 |
| Acute Hyperglycemia Promotes a Proinflammatory Monocyte Phenotype to Drive Glomerular Injury in People with Diabetic Kidney Disease and Type 1 Diabetes | Cleveland Clinic Foundation | Rong Mei Zhang | Improving Lives | 01-July-2026 to 31-December-2027 | $74,999.40 |
| Spotlight-AQ 2 Center RCT | Children’s Mercy Hospital | Cintya Schweisberger | Improving Lives | 01-September-2023 to 31-August-2026 | $710,434.16 |
| Leveraging humoral immunity to promote commensal microbial protection from T1D | Children’s Hospital of Philadelphia | Michael Silverman | Cures | 01-May-2020 to 30-April-2026 | $749,994.60 |
| Engineering and Translational Control of Vascularization for Durable Islet Replacement Therapies | Cedars-Sinai Medical Center | Dhruv Sareen | Cures | 01-October-2026 to 30-September-2029 | $899,998.80 |
| Scalable GMP-Compliant Manufacturing of iPSC-Derived Insulin-Producing Cells: From Seed Train to Cryopreserved Product | Cedars-Sinai Medical Center | Dhruv Sareen | Cures | 01-April-2026 to 31-March-2028 | $600,000.00 |